期刊
MUCOSAL IMMUNOLOGY
卷 10, 期 5, 页码 1310-1319出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/mi.2016.129
关键词
-
类别
资金
- Canadian Institutes of Health Research [TMI-138656, OCH-131579]
- Ontario HIV Treatment Network
- University of Toronto-OHTN Endowed Chair in HIV Research
- National Institute of Allergy and Infectious Diseases of the National Institute of Health [U19AI084044, R01AI116799]
Cervical human papillomavirus (HPV) infection may increase HIV risk. Since other genital infections enhance HIV susceptibility by inducing inflammation, we assessed the impact of HPV infection and clearance on genital immunology and the cervico-vaginal microbiome. Genital samples were collected from 65 women for HPV testing, immune studies and microbiota assessment; repeat HPV testing was performed after 6 months. All participants were HIV-uninfected and free of bacterial STIs. Cytobrush-derived T cell and dendritic cell subsets were assessed by multiparameter flow cytometry. Undiluted cervico-vaginal secretions were used to determine cytokine levels by multiplex ELISA, and to assess bacterial community composition and structure by 16S rRNA gene sequence analysis. Neither HPV infection nor clearance were associated with broad differences in cervical Tcell subsets or cytokines, although HPV clearance was associated with increased Langerhans cells and HPV infection with elevated IP-10 and MIG. Individuals with HPV more frequently had a high diversity cervico-vaginal microbiome (community state type IV) and were less likely to have an L. gasseri predominant microbiome. In summary, HPV infection and/or subsequent clearance was not associated with inflammation or altered cervical Tcell subsets, but associations with increased Langerhans cells and the composition of the vaginal microbiome warrant further exploration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据